{"id":"https://openalex.org/W112367184","doi":null,"title":"Rituximab for refractory polymyositis: an open-label prospective study.","display_name":"Rituximab for refractory polymyositis: an open-label prospective study.","publication_year":2007,"publication_date":"2007-09-01","ids":{"openalex":"https://openalex.org/W112367184","mag":"112367184","pmid":"https://pubmed.ncbi.nlm.nih.gov/17722224"},"language":"en","primary_location":{"id":"pmid:17722224","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17722224","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of rheumatology","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033947419","display_name":"Chi Chiu Mok","orcid":"https://orcid.org/0000-0003-3696-1228","observed_orcids":["https://orcid.org/0000-0003-3696-1228"]},"institutions":[{"id":"https://openalex.org/I2800783597","display_name":"Tuen Mun Hospital","ror":"https://ror.org/018nkky79","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I1294586568","https://openalex.org/I2800783597"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chi Chiu Mok","raw_affiliation_strings":["Department of Medicine, Tuen Mun Hospital, Hong Kong, China. ccmok2005@yahoo.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Tuen Mun Hospital, Hong Kong, China. ccmok2005@yahoo.com","institution_ids":["https://openalex.org/I2800783597"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057647252","display_name":"Ling Yin Ho","orcid":"https://orcid.org/0000-0003-3427-327X","observed_orcids":["https://orcid.org/0000-0003-3427-327X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ling Yin Ho","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5101439084","display_name":"Chi Hung To","orcid":"https://orcid.org/0000-0002-5219-4332","observed_orcids":["https://orcid.org/0000-0002-5219-4332"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chi Hung To","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.8112,"has_fulltext":false,"cited_by_count":112,"citation_normalized_percentile":{"value":0.97071665,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"34","issue":"9","first_page":"1864","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":1.0},{"id":"https://openalex.org/keywords/inflammatory-myopathies","display_name":"myositis","score":0.5759999752044678},{"id":"https://openalex.org/keywords/proximal-muscle-weakness","display_name":"proximal muscle weakness","score":0.8169999718666077},{"id":"https://openalex.org/keywords/creatine-kinase","display_name":"creatine kinase","score":0.968999981880188},{"id":"https://openalex.org/keywords/disease-activity","display_name":"disease activity","score":0.6430000066757202},{"id":"https://openalex.org/keywords/disability","display_name":"disability","score":0.9639999866485596},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.8930000066757202},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.7749999761581421},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.578000009059906},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.7310000061988831}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9538019895553589},{"id":"https://openalex.org/C2779387793","wikidata":"https://www.wikidata.org/wiki/Q980926","display_name":"Polymyositis","level":2,"score":0.8892107009887695},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.8056843280792236},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6304831504821777},{"id":"https://openalex.org/C2781232998","wikidata":"https://www.wikidata.org/wiki/Q1433212","display_name":"Myositis","level":2,"score":0.6199504137039185},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.49505749344825745},{"id":"https://openalex.org/C36880943","wikidata":"https://www.wikidata.org/wiki/Q409458","display_name":"Creatine kinase","level":2,"score":0.4642511010169983},{"id":"https://openalex.org/C2776418732","wikidata":"https://www.wikidata.org/wiki/Q270421","display_name":"Muscle weakness","level":2,"score":0.44045987725257874},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.42370834946632385},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3856656551361084},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.34118324518203735},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.12174364924430847},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006233","descriptor_name":"Persons with Disabilities","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017285","descriptor_name":"Polymyositis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020127","descriptor_name":"Recovery of Function","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D053580","descriptor_name":"Muscle Strength","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:17722224","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17722224","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of rheumatology","raw_type":"Clinical Trial"},{"id":"mag:112367184","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17722224","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7096050801","https://openalex.org/W1813981428","https://openalex.org/W2773347049","https://openalex.org/W3112231084","https://openalex.org/W2113708579","https://openalex.org/W2076417190","https://openalex.org/W2333179445","https://openalex.org/W2097392615","https://openalex.org/W2152530416","https://openalex.org/W2107382695"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"report":[2],"the":[3,10,118,144,186,192],"efficacy":[4],"and":[5,33,45,87,95,117,150,184,188],"toxicity":[6],"of":[7,12,35,80,91,97,121,165,179,191],"rituximab":[8,59],"in":[9,143,152,155,172,181,213],"treatment":[11],"refractory":[13,42,214],"polymyositis.":[14],"METHODS:":[15],"Adult":[16],"patients":[17,102,162],"with":[18,169],"active":[19,36,131],"polymyositis":[20,122],"as":[21],"evidenced":[22],"by":[23,64],"persistent":[24],"proximal":[25,146],"muscle":[26,81,84,147,167],"weakness,":[27],"elevated":[28],"creatine":[29],"kinase":[30],"(CK)":[31],"level,":[32],"features":[34],"myositis":[37,132],"on":[38],"electromyography":[39],"who":[40],"were":[41,52,57,73,107,159],"to":[43,157,210,222],"corticosteroids":[44],"at":[46,134],"least":[47,135],"2":[48,136],"other":[49],"immunosuppressive":[50,55],"agents":[51,56],"recruited.":[53],"While":[54],"continued,":[58],"(375":[60],"mg/m2)":[61],"was":[62,112,123,176,202],"given":[63],"intravenous":[65],"infusion":[66],"weekly":[67],"for":[68,77,133],"4":[69],"consecutive":[70],"weeks.":[71],"Patients":[72],"followed":[74],"up":[75],"4-weekly":[76],"serial":[78],"assessment":[79],"power,":[82],"serum":[83],"enzymes,":[85],"physician's":[86],"patient's":[88],"global":[89],"impression":[90],"disease":[92],"activity,":[93],"disability,":[94],"quality":[96],"life":[98],"scores.":[99,200],"RESULTS:":[100],"Four":[101],"(3":[103],"women,":[104],"1":[105],"man)":[106],"studied.":[108],"The":[109],"mean":[110,119,145],"age":[111],"53":[113],"+/-":[114,125],"11":[115],"years":[116],"duration":[120],"4.8":[124],"3.3":[126],"years.":[127,137],"All":[128],"had":[129,163],"persistently":[130],"At":[138],"Week":[139],"28,":[140],"significant":[141,170],"improvement":[142,180],"power":[148,168],"scores":[149,183],"reduction":[151],"CK":[153,173],"levels":[154],"comparison":[156],"baseline":[158],"observed.":[160],"Two":[161],"return":[164],"full":[166],"drop":[171],"level.":[174],"There":[175],"a":[177],"trend":[178],"disability":[182],"both":[185],"mental":[187],"physical":[189],"components":[190],"Medical":[193],"Outcomes":[194],"Study":[195],"Short":[196],"Form-36":[197],"Health":[198],"Survey":[199],"Rituximab":[201,206],"well":[203],"tolerated.":[204],"CONCLUSION:":[205],"is":[207],"an":[208],"option":[209],"be":[211],"considered":[212],"polymyositis,":[215],"but":[216],"further":[217],"controlled":[218],"trials":[219],"are":[220],"necessary":[221],"confirm":[223],"its":[224],"efficacy.":[225]},"counts_by_year":[{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}